A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Atopic Dermatitis
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04271514
- Collaborators
- Not Provided
- Investigators
- Study Director: Laurence Cheng, MD, PhD RAPT Therepeutics, Inc.